Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,124.27
    +45.41 (+0.56%)
     
  • Bitcoin USD

    64,420.00
    +1,013.54 (+1.60%)
     
  • CMC Crypto 200

    1,329.09
    -67.45 (-4.83%)
     
  • S&P 500

    5,093.78
    +45.36 (+0.90%)
     
  • Dow

    38,228.02
    +142.22 (+0.37%)
     
  • Nasdaq

    15,869.86
    +258.10 (+1.65%)
     
  • Gold

    2,351.80
    +9.30 (+0.40%)
     
  • Crude Oil

    84.07
    +0.50 (+0.60%)
     
  • 10-Yr Bond

    4.6610
    -0.0450 (-0.96%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why PetMed Express Was a Dog of a Stock This Week

Why PetMed Express Was a Dog of a Stock This Week

While animal healthcare specialist PetMed Express (NASDAQ: PETS) advertises itself as "your trusted pet expert," the stock market wasn't trusting it as a solid investment this week. According to data compiled by S&P Global Market Intelligence, the company's shares fell by 13% for the week, largely due to its lackluster quarterly results. In the third quarter of its fiscal 2023, PetMed Express booked $58.9 million in net sales, a slight drop from the $60.7 million it made in the same quarter of the previous fiscal year.